J. Scott Garland insider trades
Open-market stock purchases and sales by J. Scott Garland, Unknown at Olema Pharmaceuticals, Inc, from SEC Form 4 filings since Oct 20, 2011.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | OLMA Olema Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 3, 2026 | LBRX LB Pharmaceuticals Inc | Bought (not open market) | — |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | $432K |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | $258K |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | $337K |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | $291K |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | $158K |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Feb 12, 2026 | ELVN Enliven Therapeutics, Inc | Bought (not open market) | — |
| Jan 20, 2026 | ALXO ALX Oncology Holdings Inc | Bought (not open market) | — |
| Jan 7, 2026 | ELVN Enliven Therapeutics, Inc | Bought (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- OLMA Olema Pharmaceuticals, Inc: other filings, last Jun 18, 2026
- LBRX LB Pharmaceuticals Inc: other filings, last Jun 3, 2026
- DAWN Day One Biopharmaceuticals, Inc: other filings, last Apr 23, 2026
- ELVN Enliven Therapeutics, Inc: other filings, last Feb 12, 2026
- ALXO ALX Oncology Holdings Inc: other filings, last Jan 20, 2026
- CALA Calithera Biosciences, Inc: other filings, last Jun 1, 2022
- PTLA Portola Pharmaceuticals Inc: other filings, last Jul 2, 2020
- KPTI Karyopharm Therapeutics Inc: other filings, last Jun 6, 2019
- RLYP Relypsa Inc: other filings, last Sep 1, 2016
- EXEL Exelixis, Inc: other filings, last Sep 18, 2013